Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE
Document Type and Number:
WIPO Patent Application WO/2019/004980
Kind Code:
A3
Abstract:
The present invention relates to solid oral pharmaceutical compositions, comprising dabigatran etexilate in the form of the free base or in the form of pharmaceutically acceptable salts, polymorphs, solvates, hydrates or esters thereof.

Inventors:
TÜRKYILMAZ ALI (TR)
PALANTÖKEN ARZU (TR)
URAZ EZEL (TR)
GÜLKOK YILDIZ (TR)
Application Number:
PCT/TR2018/050221
Publication Date:
April 11, 2019
Filing Date:
May 10, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR)
International Classes:
A61K9/48; A61K9/16; A61K9/50; A61K31/4439
Domestic Patent References:
WO2016142821A22016-09-15
WO2013124340A12013-08-29
WO2012001156A22012-01-05
Foreign References:
CN104095830A2014-10-15
CN105560206A2016-05-11
CN104784147A2015-07-22
EP2929884A12015-10-14
Other References:
DATABASE WPI Section Ch Week 201675, Derwent World Patents Index; Class A96, AN 2016-637397, XP002789451, BALANAGU H B; BALEBOINA S; BEJAWADA S; CHERUVU R; HILL L A: "Capsule dosage form of direct thrombin inhibitor, useful e.g. for treating deep venous thrombosis and pulmonary embolism, and for reducing risk of stroke and systemic embolism, comprises two types of solid unit dosage forms"
Attorney, Agent or Firm:
SEVINC, Erkan (TR)
Download PDF: